Omentin-1 vs Leuprolide
Head-to-head comparison of Omentin-1 (Omentin-1 (Intelectin-1, ITLN1)) and Leuprolide (Leuprolide acetate) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Omentin-1 | Leuprolide |
|---|---|---|
| Category | Diabetes & Metabolic | Sexual Health |
| Full Name | Omentin-1 (Intelectin-1, ITLN1) | Leuprolide acetate |
| Molecular Weight | ~35 kDa | 1209.39 Da |
| Half-Life | hours | ~3 hours; depot lasts weeks |
| Amino Acids | 313 | 9 |
| Typical Dose | No approved human dose; research use only | 0.1 mg SC daily|3.75 mg IM monthly|11.25 mg depot per protocol |
| Route | IV|SC | Subcutaneous/Intramuscular |
| Purity | ≥98% | ≥98% |
| Studies Count | 82 | 1200 |
| Research Status | Pre-clinical | Clinical |
Omentin-1 Benefits
- ✓insulin sensitivity
- ✓glucose uptake
- ✓lipid handling
Leuprolide Benefits
- ✓pituitary suppression
- ✓cycle synchronization
- ✓ovarian stimulation timing
- ✓endometriosis-related reproductive care
Omentin-1 Dosing
not established|not established
Leuprolide Dosing
0.1 mg SC daily|3.75 mg IM monthly depot|11.25 mg 3-month depot
Omentin-1 Side Effects
- ⚠unknown
- ⚠immunogenicity risk
Leuprolide Side Effects
- ⚠hot flashes
- ⚠decreased libido
- ⚠injection-site reactions
Research Overview
Omentin-1
Lower omentin-1 levels are often associated with obesity, insulin resistance, and metabolic syndrome. Research continues on its use as a biomarker and as a mechanistic lead for AMPK-linked metabolic interventions.
Leuprolide
Leuprolide is one of the best-studied GnRH analogs in reproductive medicine and assisted reproduction. It produces an initial flare followed by receptor desensitization and reduced LH/FSH output.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.